Bessemer Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bessemer Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,511	Closed	-$415K	–	1793
2021 Q2	$415K	Hold	2,511	–	–	﹤0.01%	619
2021 Q1	$385K	Buy	2,511 +110	+5%	+$14.9K	﹤0.01%	606
2020 Q4	$301K	Buy	2,401 +205	+9%	+$22.9K	﹤0.01%	638
2020 Q3	$223K	Sell	2,196 -7,949	-78%	-$810K	﹤0.01%	701
2020 Q2	$987K	Buy	+10,145	New	+$944K	﹤0.01%	792
2019 Q4	–	Sell	-16	Closed	-$2K	–	1819
2019 Q3	$2K	Buy	+16	New	+$1.59K	﹤0.01%	1635
2018 Q3	–	Sell	-7,000	Closed	-$654K	–	1922
2018 Q2	$654K	Sell	7,000 -500	-7%	-$43.1K	﹤0.01%	685
2018 Q1	$622K	Buy	+7,500	New	+$666K	﹤0.01%	712

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Bessemer Group's PRAH Position: Q3 2021 in Review

Bessemer Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,511 shares — an estimated $415K sold.

Bessemer Group first reported a position in PRAH in Q1 2018 and held it in 8 quarters. The position peaked at $987K in Q2 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Bessemer Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Bessemer Group sold 2,511 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $415K.
Bessemer Group first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 8 quarters.
Bessemer Group's PRA Health Sciences, Inc. position peaked at $987K in Q2 2020.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Bessemer Group's 13F filing for Q3 2021, filed 12 Nov 2021.